Mixtard to Glargine Dose Conversion
When converting from Mixtard (premixed 30/70 insulin) to insulin glargine, start with 80% of the total daily Mixtard dose as the initial glargine dose, administered once daily. This dose reduction is critical to minimize hypoglycemia risk during the transition 1.
Conversion Algorithm
Step 1: Calculate Total Daily Mixtard Dose
- Add up all Mixtard injections given in 24 hours (typically twice daily dosing)
Step 2: Apply the 80% Reduction Rule
- Initial glargine dose = 0.8 × total daily Mixtard dose
- This follows the FDA-approved conversion guidance for switching from twice-daily NPH (the basal component of Mixtard) to once-daily glargine 1
Step 3: Titration Strategy
After initiating glargine at 80% of the previous Mixtard dose:
- Target fasting plasma glucose (FPG) as your primary endpoint
- Increase glargine by 2 units every 3 days until FPG goal is achieved without hypoglycemia 2
- If hypoglycemia occurs without clear cause, reduce dose by 10-20% 2
Critical Monitoring Requirements
Intensify blood glucose monitoring during the conversion period 1. The loss of the short-acting component from Mixtard means:
- Postprandial glucose may initially rise
- Risk of hypoglycemia changes from predominantly pre-lunch/pre-dinner (with Mixtard) to overnight/fasting periods (with glargine)
Managing the Prandial Coverage Gap
Since Mixtard contains 30% short-acting insulin that covers meals, you have three options when switching:
Add a GLP-1 receptor agonist (preferred if not already on one) to address postprandial glucose without adding injection burden 2
Add prandial insulin if A1C remains above goal after optimizing basal glargine:
- Start with 4 units or 10% of basal dose at the largest meal 2
- Titrate based on postprandial glucose readings
Optimize oral antidiabetic drugs (particularly metformin) in combination with glargine 3
Patient-Specific Considerations
Better responders to this conversion (those more likely to achieve A1C <7%) have 4, 5:
- Younger age
- Shorter diabetes duration
- Lower baseline HbA1c and FPG
- Higher postprandial C-peptide (better preserved beta-cell function)
- Lower baseline insulin requirements
Patients with higher baseline HbA1c (>8.5%) will see the greatest absolute improvement in glycemic control but may require more aggressive titration and potentially earlier addition of prandial coverage 4.
Common Pitfalls to Avoid
- Do NOT convert unit-for-unit: This significantly increases hypoglycemia risk, particularly nocturnal hypoglycemia
- Do NOT abruptly discontinue oral medications during the switch—this causes rebound hyperglycemia 6
- Do NOT under-titrate: Three-quarters of patients who fail to achieve A1C <7% also fail to reach FPG ≤6.1 mmol/L, indicating inadequate basal insulin titration 4
- Rotate injection sites properly to avoid lipodystrophy, which can cause erratic insulin absorption and glycemic variability 1
Practical Example
If a patient is taking Mixtard 30 units before breakfast and 20 units before dinner (total 50 units/day):
- Initial glargine dose = 50 × 0.8 = 40 units once daily
- Administer at the same time each day (any time, but consistent)
- Titrate upward by 2 units every 3 days based on FPG readings
- Monitor for postprandial hyperglycemia and address with GLP-1 RA or prandial insulin as needed